Multidimensional imaging techniques for prediction of treatment response in major depressive disorder

Scott A. Langenecker, Heide Klumpp, Amy T. Peters, Natania A. Crane, Sophie R. DelDonno, Katie L. Bessette, Olusola Ajilore, Alex Leow, Stewart A. Shankman, Sara J. Walker, Michael T. Ransom, David T. Hsu, K. Luan Phan, Jon Kar Zubieta, Brian J. Mickey, Jonathan P. Stange

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


A large number of studies have attempted to use neuroimaging tools to aid in treatment prediction models for major depressive disorder (MDD). Most such studies have reported on only one dimension of function and prediction at a time. In this study, we used three different tasks across domains of function (emotion processing, reward anticipation, and cognitive control, plus resting state connectivity completed prior to start of medication to predict treatment response in 13–36 adults with MDD. For each experiment, adults with MDD were prescribed only label duloxetine (all experiments), whereas another subset were prescribed escitalopram. We used a KeyNet (both Task derived masks and Key intrinsic Network derived masks) approach to targeting brain systems in a specific match to tasks. The most robust predictors were (Dichter et al., 2010) positive response to anger and (Gong et al., 2011) negative response to fear within relevant anger and fear TaskNets and Salience and Emotion KeyNet (Langenecker et al., 2018) cognitive control (correct rejections) within Inhibition TaskNet (negative) and Cognitive Control KeyNet (positive). Resting state analyses were most robust for Cognitive control Network (positive) and Salience and Emotion Network (negative). Results differed by whether an -fwhm or -acf (more conservative) adjustment for multiple comparisons was used. Together, these results implicate the importance of future studies with larger sample sizes, multidimensional predictive models, and the importance of using empirically derived masks for search areas.

Original languageEnglish (US)
Pages (from-to)38-48
Number of pages11
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
StatePublished - Apr 20 2019

ASJC Scopus subject areas

  • Pharmacology
  • Biological Psychiatry


Dive into the research topics of 'Multidimensional imaging techniques for prediction of treatment response in major depressive disorder'. Together they form a unique fingerprint.

Cite this